Drug/Small Molecule:
loxapine

2D structure

Overview

Trade Names: Cloxazepine; Dibenzacepin; Dibenzoazepine; Hydrofluoride 3170; Lossapina [Dcit]; Loxapac; Loxapin; Loxapina [INN-Spanish]; Loxapine [Usan:Ban:Inn]; Loxapinum [INN-Latin]; Loxepine; Loxitane C; Loxitane Im; Oxilapine
PharmGKB Accession Id: PA450273

Description

An antipsychotic agent used in schizophrenia. PubChem (source: Drug Bank)

Indication

For the management of the manifestations of psychotic disorders (source: Drug Bank)

ATC Therapeutic Category

  • N05AH:Diazepines, oxazepines and thiazepines

Pharmacology, Interactions, and Contraindications

Mechanism Of Action

Loxapine is a dopamine antagonist, and also a serotonin 5-HT2 blocker. The exact mode of action of Loxapine has not been established, however changes in the level of excitability of subcortical inhibitory areas have been observed in several animal species in association with such manifestations of tranquilization as calming effects and suppression of aggressive behavior. (source: Drug Bank)

Pharmacology

Loxapine, a dibenzoxazepine compound, represents a subclass of tricyclic antipsychotic agents, chemically distinct from the thioxanthenes, butyrophenones, and phenothiazines. Pharmacologically, Loxapine is a tranquilizer for which the exact mode of action has not been established. (source: Drug Bank)

Food Interactions

Take with food to reduce irritation. Avoid alcohol. (source: Drug Bank)

Absorption, Distribution, Metabolism, Elimination & Toxicity

Biotransformation

Hepatic (source: Drug Bank)

Absorption

Systemic bioavailability of the parent drug was only about one third that after an equivalent intramuscular dose (25 mg base) in male volunteers (source: Drug Bank)

Toxicity

LD<sub>50</sub>=65 mg/kg (Orally in mice) (source: Drug Bank)

Isomeric SMILES Code:

CN1CCN(CC1)C2=Nc3ccccc3Oc4c2cc(cc4)Cl (source: Drug Bank)

A list of non-curated publications that mention this drug along with other genes is available.

Drug Targets

Gene Description
DRD1 Uncurated Annotation (source: Drug Bank)
DRD2 Uncurated Annotation (source: Drug Bank)

A list of non-curated publications that mention this drug along with other drugs is available.

Drug Interactions

Drug Description
donepezil Uncurated Annotation Possible antagonism of action (source: Drug Bank)
galantamine Uncurated Annotation Possible antagonism of action (source: Drug Bank)
rivastigmine Uncurated Annotation Possible antagonism of action (source: Drug Bank)

Curated Information

The following diseases are in curated knowledge about this drug.

  Disease Relationship Evidence
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Parkinson Disease
  •   
  • PD
  •   
  •   
  •   
Publications

Non-Curated Information

A list of non-curated publications that mention this drug along with other diseases is available.

Additional Datasets

These datasets are minimally curated and are sorted alphabetically by title.

  1. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

LinkOuts

Web Resource:
Wikipedia
DrugBank:
DB00408
KEGG Compound ID:
C07104
KEGG Drug ID:
D02340
PubChem Compound ID:
3964
PubChem Substance ID:
9315
IUPHAR Ligand ID:
205

Common Searches

Search PubMed
Search Medline Plus
Search PubChem
Search CTD

Non-Curated Publications

A list of non-curated publications that mention this drug is available.

PharmGKB integrates drug information from different sources: DrugBank, Open Eye Scientific Software.
Add New Alternate Name
Add New ATC Term
Add Cross Reference
Add a metabolite
Add a text annotation
Add a drug target
hint: enter a gene
    Add a drug interaction
    hint: enter a drug
    PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (GM61374).
    ©2001-2010 PharmGKB.